Clinical trial
Study on the Dimethyl Fumarate (DMF, Tecfidera®) Persistence of Remitting-relapsing Multiple Sclerosis (RR-MS) Patients Included in the French Patient Support Program (PSP) OroSEP
NCT04221191 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Dimethyl Fumarate (DMF, Tecfidera®) Persistence of Remitting-relapsing Multiple Sclerosis (RR-MS) Patients Included in the French Patient Support Program (PSP) OroSEP
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 19, 2019
- Completion date
- September 14, 2022
- Enrollment
- 353 (actual)
- Sites
- 63
Conditions
As the registry lists them; a condition with its own page is linked.